{
    "paper_id": "7f12da49588de3778cbe3540740d4ba680a1ca01",
    "metadata": {
        "title": "Myasthenic crisis in COVID-19",
        "authors": [
            {
                "first": "R",
                "middle": [
                    "P"
                ],
                "last": "Syed",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Lisak",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "The neurotropic potential and the neurological complications of coronavirus disease are still being uncovered, those documented so far include headaches, acute cerebrovascular incidents, anosmia, post-infectious disseminated and brainstem encephalitis and viral meningitis [1] and Guillain-Barr\u00e9 Syndrome [2] . Myasthenia gravis (MG) patients are particularly susceptible to infections causing crises due to the combination of reduced neuromuscular safety factors adversely affected by pyrexia and the effect of acute inflammatory mediators compounded by immunosuppression in many patients [3, 4] . Acute respiratory distress (ARDS) seen in COVID-19 coupled with respiratory muscle failure seen in MG crises may result in a dire prognosis. We present a case of a 56-year-old woman who developed MG crisis and concomitant COVID-19.",
            "cite_spans": [
                {
                    "start": 273,
                    "end": 276,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 305,
                    "end": 308,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 590,
                    "end": 593,
                    "text": "[3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 594,
                    "end": 596,
                    "text": "4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Dear Editor,"
        },
        {
            "text": "The patient is a 56-year-old woman with a history of acetylcholine receptor antibody (AChR-Ab) positive MG for over five years maintained on pyridostigmine 60 mg four times daily, prednisone 20 mg twice a day and intravenous immunoglobulin (IVIG) infusions (650 mg/kg for two days every two weeks). The patient had refused thymectomy. She also took hydroxychloroquine 200 mg twice daily for mixed connective tissue disease. Her exacerbations typically consisted of weakness of her lower extremities, ptosis and dysphagia but no history of mechanical ventilator support. She presented to the emergency department with dyspnea, fevers, rhinorrhea and diffuse myalgias. She had 70% oxygen saturation, was placed on 15 L of oxygen on non-rebreather but continued to deteriorate requiring mechanical ventilation. Initial chest x-ray showed bi-basilar infiltrates compatible with pneumonia ( Figure 1A) . She was started on vancomycin, cefepime, azithromycin and prednisone was increased to 40 mg twice We present this first known case in the literature of MG crises with simultaneous COVID-19.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 886,
                    "end": 896,
                    "text": "Figure 1A)",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "Dear Editor,"
        },
        {
            "text": "Recent guidelines for the management of MG during the COVID-19 pandemic suggest individualized therapy, however, MG crises has not been addressed as a potential complication of COVID-19 [4] . While coronavirus infections have not been documented as a cause of MG crisis, viral infections in general have been reported to trigger autoimmunity through",
            "cite_spans": [
                {
                    "start": 186,
                    "end": 189,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Dear Editor,"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Neurologic complications of coronavirus infections",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nath",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Neurology",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Guillain-Barre syndrome related to COVID-19 infection",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Alberti",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Beretta",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Piatti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Karantzoulis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Piatti",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Santoro",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Vigano",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Giovannelli",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Pirro",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Montisano",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Appollonio",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ferrarese",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Neurol Neuroimmunol Neuroinflamm",
            "volume": "7",
            "issn": "4",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "COVID-19 and neuromuscular disorders",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Guidon",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Amato",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Neurology",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "C.-W",
                    "middle": [
                        "G"
                    ],
                    "last": "International",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jacob",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Muppidi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Guidon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guptill",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hehir",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Howard",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Illa",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Mantegazza",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Murai",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Utsugisawa",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Vissing",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Wiendl",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Nowak",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Neurol Sci",
            "volume": "412",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Myasthenia gravis and infectious disease",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "E"
                    ],
                    "last": "Gilhus",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Romi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "O"
                    ],
                    "last": "Skeie",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Neurol",
            "volume": "265",
            "issn": "6",
            "pages": "1251--1258",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Molecular immune pathogenesis and diagnosis of COVID-19",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Geng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Meng",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Pharm Anal",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Treatment of myasthenia gravis based on its immunopathogenesis",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "D"
                    ],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "P"
                    ],
                    "last": "Richman",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Clin Neurol",
            "volume": "7",
            "issn": "4",
            "pages": "173--83",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Current status of potential therapeutic candidates for the COVID-19 crisis",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hashimoto",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Brain Behav Immun",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Marie",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Maurey",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Herve",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Hellot",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Levesque",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Br J Dermatol",
            "volume": "155",
            "issn": "4",
            "pages": "714--735",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Incidence of thrombotic complications in critically ill ICU patients with COVID-19",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Klok",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kruip",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "J M"
                    ],
                    "last": "Van Der Meer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Arbous",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Gommers",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Kant",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "H J"
                    ],
                    "last": "Kaptein",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Van Paassen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A M"
                    ],
                    "last": "Stals",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "V"
                    ],
                    "last": "Huisman",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Endeman",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Thromb Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "A and B testing was negative but COVID-19 (confirmed by CDC COVID-19 realtime RT PCR on Roche cyclers) was reported positive on day 2 of admission. Antibiotics were stopped and hydroxychloroquine, 200mg daily was resumed. On Day 3, neurology recommended restarting pyridostigmine and IVIG 400 mg/kg for five days. Neurological examination prior to IVIG was significant for motor strength of 4/5 in the proximal upper and lower extremities, intact cranial nerves with speech and swallowing function difficult to assess due to intubation. Worsening respiratory status and bilateral pulmonary infiltrates required prone positioning for 16 hours on days 6 and 7 (Figure1B). Patient showed improvement on ventilator settings after her fifth IVIG dose on day 8 and continued to improve over the course of treatment. Patient was extubated and placed on CPAP on day 13 and 4L Oxygen by nasal cannula (NC) on day 15 with chest x-ray showing improved bilateral infiltrates (Figure 1C).However, due to worsening proximal weakness of upper and lower extremities (2/5), she received another course of IVIG 650 mg/kg two days in a row. Repeat COVID-19 testing was positive on Day 19. By day 25, patient was able to stand, walk 4-5 steps and required 3 L oxygen by NC with chest x-ray remaining stable (Figure 1D). Patient was awaiting placement for subacute rehab facility.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Sequential chest radiographs of patient with COVID-19 and myasthenic crises Chest radiographs of bilateral pneumonia progression on days 1(A) and 6(B) and improvement on days 15(C) and 25(D).",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}